About VIDD

Headquartered at Fred Hutch, HVTN is an international partnership of research scientists, clinical trial sites, laboratories and others engaged in the global search for a preventive HIV vaccine. The network includes more than 30 sites on five continents. VIDD member and Fred Hutch President Emeritus Dr. Larry Corey has led the worldwide initiative since its inception in 1999. Dr. Julie McElrath, Director of VIDD and IVD, directs the laboratory component of this initiative. Its statistical components are directed by BBE head, Dr. Peter Gilbert. Collectively, research conducted by the network has transformed care for HIV/AIDS patients worldwide.

Striving to eliminate infectious diseases and to reduce the global burden of cancer, VIDD scientists conduct research across the globe. Our members maintain laboratory, clinical and field sites in the Americas, Africa, Asia and Europe. Our division has specific initiatives in Uganda, China and the Republic of South Africa to advance the understanding of infection-related cancers and infectious diseases that affect high-risk populations in these regions.   In partnership with Fred Hutch’s Global Oncology Program, our decade-long collaboration with the Uganda Cancer Institute has yielded a new facility, tools and treatments that will save lives in low-resource countries worldwide. Patients now have access to the latest diagnostic methods and clinical care standards. Scientists can conduct advanced experiments with state-of-the-art equipment, while accessing local clinical cohorts as well as datasets and a large repository of well-characterized specimens. This will better enable scientists to study emerging infections and cancers caused by viruses and other pathogens.